Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Long noncoding RNA H19X is a key mediator of TGF-β–driven fibrosis
Elena Pachera, … , Mojca Frank-Bertoncelj, Oliver Distler
Elena Pachera, … , Mojca Frank-Bertoncelj, Oliver Distler
Published June 30, 2020
Citation Information: J Clin Invest. 2020;130(9):4888-4905. https://doi.org/10.1172/JCI135439.
View: Text | PDF
Research Article Autoimmunity Cell biology

Long noncoding RNA H19X is a key mediator of TGF-β–driven fibrosis

  • Text
  • PDF
Abstract

TGF-β is a master regulator of fibrosis, driving the differentiation of fibroblasts into apoptosis-resistant myofibroblasts and sustaining the production of extracellular matrix (ECM) components. Here, we identified the nuclear long noncoding RNA (lncRNA) H19X as a master regulator of TGF-β–driven tissue fibrosis. H19X was consistently upregulated in a wide variety of human fibrotic tissues and diseases and was strongly induced by TGF-β, particularly in fibroblasts and fibroblast-related cells. Functional experiments following H19X silencing revealed that H19X was an obligatory factor for TGF-β–induced ECM synthesis as well as differentiation and survival of ECM-producing myofibroblasts. We showed that H19X regulates DDIT4L gene expression, specifically interacting with a region upstream of the DDIT4L gene and changing the chromatin accessibility of a DDIT4L enhancer. These events resulted in transcriptional repression of DDIT4L and, in turn, in increased collagen expression and fibrosis. Our results shed light on key effectors of TGF-β–induced ECM remodeling and fibrosis.

Authors

Elena Pachera, Shervin Assassi, Gloria A. Salazar, Mara Stellato, Florian Renoux, Adam Wunderlin, Przemyslaw Blyszczuk, Robert Lafyatis, Fina Kurreeman, Jeska de Vries-Bouwstra, Tobias Messemaker, Carol A. Feghali-Bostwick, Gerhard Rogler, Wouter T. van Haaften, Gerard Dijkstra, Fiona Oakley, Maurizio Calcagni, Janine Schniering, Britta Maurer, Jörg H.W. Distler, Gabriela Kania, Mojca Frank-Bertoncelj, Oliver Distler

×

Figure 4

H19X silencing triggers fibroblast apoptosis.

Options: View larger image (or click on image) Download as PowerPoint
H19X silencing triggers fibroblast apoptosis.
H19X was silenced in derma...
H19X was silenced in dermal SSc fibroblasts with 25 nM ASO for a total of 120 hours and stimulated with TGF-β for the last 72 hours in 1% FBS medium. Gene ontology enrichment analysis performed on significantly upregulated genes (FDR <0.05 and absolute log2 FC >0.5) as revealed by microarray analysis (A). Heatmap showing significant upregulated genes that are relevant for cell cycle and proliferation as measured by microarray analysis (FDR < 0.05 and log2 FC >0.5) (B). H19X was silenced in SSc fibroblasts with 25 nM ASO for a total of 120 hours and stimulated with TGF-β for the last 48 hours in 1% FBS medium. Cells were stained with Hoechst 33342 and percentages of cells in G1 and G2/S, were acquired by flow cytometry. Dot plots are representative for n = 3 biological replicates (C). H19X was silenced in SSc fibroblasts with 25 nM ASO and in parallel stimulated with TGF-β. xCELLigence real-time measurement of cell proliferation. Measurement of the cell index normalized to the cell index value at the time of transfection (24 hours). Experiment was recorded for 180 hours after cell transfection. Representative normalized cell index curve of n = 5 biological replicates, variation is presented as SD of 4 technical replicates of the representative biological replicate (D). The slope of the cell index curve was calculated separately for the exponential growth phase and the late phase of the curve (E). Luminescence (for annexin V) as a measure of apoptosis was recorded every 6 hours starting 24 hours until 120 hours after cell transfection. Fold change was calculated respective to scrambled control. *indicates significance for untreated cells, +indicates significance for TGF-β–stimulated cells (F). Caspase-3/7 activity measured at 88 hours after cell transfection (f). Data are presented as single values and mean (n = 3–5). One-way ANOVA (C, E, and G). Two-way ANOVA (F). *P < 0.05, **P < 0.01, ***P < 0.001.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts